Skip to content
Modelwire
Subscribe

De la Fuente Lab uses ChatGPT to compress antibiotic discovery from years to hours

Source published ·Modelwire updated

Original coverage: OpenAI (YouTube) ↗·How Modelwire adds context

The development

The de la Fuente Lab is leveraging ChatGPT and Codex to compress antibiotic discovery timelines from years to hours by mining genetic sequences from organisms like woolly mammoths and snake venom for novel antimicrobial compounds. This represents a concrete shift in how LLMs accelerate domain-specific research workflows, particularly in biotech where computational bottlenecks have historically constrained innovation cycles. With antimicrobial resistance projected to double fatalities by 2050, the ability to rapidly screen and identify candidate molecules signals a meaningful intersection between generative AI capability and urgent public health infrastructure needs.

Modelwire’s AI-generated summary of coverage from OpenAI (YouTube).

Modelwire analysis

Explainer

Our AI-generated reading of the wider context and the next developments to watch.

The detail worth slowing down on is the source material: extinct organisms like woolly mammoths and non-human genomes like snake venom. These aren't conventional pharmaceutical libraries. The researchers are treating genomic sequence data as a kind of text corpus, which is what makes LLMs applicable at all, and that framing is doing a lot of quiet work in this story.

This is the second piece in close succession covering de la Fuente's lab and its use of Codex and ChatGPT for antimicrobial discovery. The earlier story (indexed here as 'How a researcher uses Codex and ChatGPT to search for new antimicrobial molecules') covered the same lab and the same toolset, making this essentially a companion piece rather than new ground. Taken together, the two stories establish a pattern: OpenAI is actively surfacing this research as a flagship scientific use case, which tells you something about where the company wants the conversation about LLM utility to go. The small business and accessibility stories published the same day suggest a coordinated content push across multiple verticals, not an organic news cycle.

Watch whether de la Fuente's lab publishes peer-reviewed results on any compound identified through this pipeline within the next 12 months. Validated wet-lab outcomes would separate this from a compelling workflow demo.

This interpretation is generated from the summary above and the archive coverage cited below. Our methodology · Report an error

Coverage behind this analysis

These archive entries ground the connection in our analysis. They are ordered by source publication date, with links to our coverage and the original sources.

  1. ·OpenAI

    Researcher deploys ChatGPT and Codex to identify antimicrobial drug candidates

    Researchers are leveraging large language models and code generation tools to accelerate drug discovery against antimicrobial resistance, a critical public health challenge. By applying Codex and ChatGPT to mine genomic databases for novel antimicrobial compounds, de la Fuente's lab demonstrates a concrete use case where LLMs move beyond text generation into scientific hypothesis generation and…

    Read Modelwire coverage →Original source ↗

MentionsOpenAI · ChatGPT · Codex · César de la Fuente · de la Fuente Lab

MW

How this coverage is produced

Modelwire uses AI to generate summaries and context from source headlines, snippets, and selected archive coverage. Automated checks do not verify every claim, and items are not routinely reviewed by a person before publication. Zacaria Solis operates the site. Read the linked source for the full evidence and report errors through our corrections process.

Modelwire summarizes, we don’t republish. OpenAI (YouTube) originally reported this story as “Discovering new antibiotics with ChatGPT”. The full content lives on youtube.com. If you’re a publisher and want a different summarization policy for your work, see our takedown page.

De la Fuente Lab uses ChatGPT to compress antibiotic discovery from years to hours · Modelwire